Dysregulation of the mTOR pathway secondary to mutations or a hostile microenvironment contributes to cancer and poor...

Area of Science:

• Cellular biology
• Molecular biology
• Genetics

Background:

• The mammalian target of the rapamycin (mTOR) pathway plays a crucial role in cell growth, proliferation, and survival.
• Dysregulation of the mTOR pathway is implicated in various diseases, including cancer and developmental disorders.
• Environmental factors can also influence mTOR pathway activity, impacting cellular functions.

Purpose of the Study:

• To explore the dual causes of mammalian target of the rapamycin (mTOR) pathway dysregulation: genetic mutations and adverse microenvironment conditions.
• To highlight the distinct clinical outcomes associated with each cause of mTOR pathway dysregulation.
• To provide context for further research into mTOR-related pathologies.

Main Methods:

• Review of existing literature on mTOR pathway genetics and environmental influences.
• Analysis of clinical data linking mTOR pathway mutations to specific syndromes.
• Examination of studies investigating microenvironment effects on cellular processes.

Main Results:

• Heredity mutations in genes regulating the mTOR pathway can cause syndromes like tuberous sclerosis, Peutz-Jeghers syndrome, and Cowden's disease.
• These genetic alterations are associated with abnormal cell growth, hamartomas, and cancer development.
• Adverse microenvironment conditions, independent of genetic mutations, can also disrupt mTOR signaling, potentially leading to issues such as poor wound healing.

Conclusions:

• The mammalian target of the rapamycin (mTOR) pathway is a critical regulator whose dysregulation, stemming from either genetic or environmental factors, has significant clinical consequences.
• Genetic mutations affecting the mTOR pathway are linked to cancer predisposition and hamartomatous growth syndromes.
• Environmental stressors impacting the mTOR pathway may contribute to conditions like impaired wound healing, underscoring the pathway's sensitivity to both internal and external cues.